Emavusertib (CA-4948) hydrochloride, a selective and potent IRAK4/FLT3 inhibitor, is designed for oral administration. It achieves an IC 50 of 57 nM against IRAK4 in a FRET kinase assay and demonstrates anti-tumor activity [1] [2] [3].
Molecular Weight:
527.96
CAS Number:
[2376399-42-5]
Formula:
C24H26ClN7O5
Target:
FLT|||Apoptosis|||MyD88|||NF-kappaB|||IRAK
* VAT and and shipping costs not included. Errors and price changes excepted
